NBW Capital’s Spyre Therapeutics SYRE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $291K | Hold |
19,430
| – | – | 0.06% | 82 |
|
|
2025
Q1 | $314K | Hold |
19,430
| – | – | 0.07% | 79 |
|
|
2024
Q4 | $452K | Sell |
19,430
-7,500
| -28% | -$175K | 0.08% | 78 |
|
|
2024
Q3 | $792K | Sell |
26,930
-7,430
| -22% | -$219K | 0.15% | 71 |
|
|
2024
Q2 | $808K | Hold |
34,360
| – | – | 0.16% | 74 |
|
|
2024
Q1 | $1.3M | Buy |
+34,360
| New | +$1.3M | 0.27% | 68 |
|